Your browser doesn't support javascript.
loading
Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers.
Berton, Mattia; Bettonte, Sara; Stader, Felix; Battegay, Manuel; Marzolini, Catia.
Afiliación
  • Berton M; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland.
  • Bettonte S; Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Stader F; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland.
  • Battegay M; Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Marzolini C; Certara UK Limited, Sheffield, UK.
Open Forum Infect Dis ; 10(7): ofad361, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37496606
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Suiza